A B S T R A C TWe investigate possible effects of neglecting seismic anisotropy on standard isotropic Pvelocity tomographic images of the upper mantle beneath the Baltic shield. Isotropic inversions of teleseismic P-and S-wave traveltimes exhibit alternating high-and low-velocity heterogeneities down to depths of over 400 km. Differences in tomographic inversions of SV -and SH-wave traveltimes are distinct down to depths of about 200 km and are associated with anisotropy of the lithospheric mantle. Anisotropic structures of the upper mantle affect both the P and S traveltimes, shear-wave splitting as well as the P polarization directions. Joint inversion for isotropic and anisotropic velocity perturbations is not feasible due to the limited 3-D ray coverage of available data. Therefore, we correct the input traveltimes for anisotropic contributions derived from independent analyses and then perform standard isotropic inversions. These corrections are derived either directly from directional deviations of P-wave propagation or are calculated in anisotropic models retrieved by joint inversions of bodywave anisotropic parameters (P-residual spheres and shear-wave splitting). These anisotropic models are also used to fit backazimuth variations of P-wave polarization directions. General features of tomographic images calculated from the original and the anisotropy-corrected data are similar. Amplitudes of the velocity perturbations decrease below ∼200 km depth, that is in the sub-lithospheric mantle. In general, large-scale anisotropy related to the fabrics of the continental mantle lithosphere can contaminate tomographic images in some parts of models and should not be ignored.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.